Literature DB >> 17552026

Epidemiology of hepatitis C virus infection.

Miriam J Alter1.   

Abstract

Globally, hepatitis C virus (HCV) has infected an estimated 130 million people, most of whom are chronically infected. HCV-infected people serve as a reservoir for transmission to others and are at risk for developing chronic liver disease, cirrhosis, and primary hepatocellular carcinoma (HCC). It has been estimated that HCV accounts for 27% of cirrhosis and 25% of HCC worldwide. HCV infection has likely been endemic in many populations for centuries. However, the wave of increased HCV-related morbidity and mortality that we are now facing is the result of an unprecedented increase in the spread of HCV during the 20th century. Two 20th century events appear to be responsible for this increase; the widespread availability of injectable therapies and the illicit use of injectable drugs.

Entities:  

Mesh:

Year:  2007        PMID: 17552026      PMCID: PMC4146761          DOI: 10.3748/wjg.v13.i17.2436

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  61 in total

1.  The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.

Authors:  Joseph F Perz; Gregory L Armstrong; Leigh A Farrington; Yvan J F Hutin; Beth P Bell
Journal:  J Hepatol       Date:  2006-06-23       Impact factor: 25.083

2.  Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population.

Authors:  Lu-Yu Hwang; Jennifer R Kramer; Catherine Troisi; Lara Bull; Carolyn Z Grimes; Rob Lyerla; Miriam J Alter
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

3.  Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment.

Authors:  Lorna E Thorpe; Lawrence J Ouellet; Ronald Hershow; Susan L Bailey; Ian T Williams; John Williamson; Edgar R Monterroso; Richard S Garfein
Journal:  Am J Epidemiol       Date:  2002-04-01       Impact factor: 4.897

4.  Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.

Authors:  W Hladik; P Kataaha; J Mermin; M Purdy; G Otekat; E Lackritz; M J Alter; R Downing
Journal:  Trop Med Int Health       Date:  2006-06       Impact factor: 2.622

5.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

6.  Seroprevalence, viremia and genotype distribution of hepatitis C virus: a community-based population study in northern Italy.

Authors:  C Campello; A Poli; Molin G Dal; F Besozzi-Valentini
Journal:  Infection       Date:  2002-01       Impact factor: 3.553

7.  Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy.

Authors:  E Spada; A Mele; M Ciccozzi; M E Tosti; E Bianco; A Szklo; P Ragni; G Gallo; E Balocchini; M Sangalli; P L Lopalco; A Moiraghi; T Stroffolini
Journal:  Dig Liver Dis       Date:  2001-12       Impact factor: 4.088

8.  Hepatitis c in a community in Upper Egypt: risk factors for infection.

Authors:  Ahmed Medhat; Magda Shehata; Laurence S Magder; Nabiel Mikhail; Laila Abdel-Baki; Mohamed Nafeh; Mohamed Abdel-Hamid; G Thomas Strickland; Alan D Fix
Journal:  Am J Trop Med Hyg       Date:  2002-05       Impact factor: 2.345

9.  Infectivity of hepatitis C virus in plasma after drying and storing at room temperature.

Authors:  Saleem Kamili; Kris Krawczynski; Karen McCaustland; Xiaofang Li; Miriam J Alter
Journal:  Infect Control Hosp Epidemiol       Date:  2007-04-16       Impact factor: 3.254

10.  Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission.

Authors:  Rosa Di Stefano; Tommaso Stroffolini; Donatella Ferraro; Antonella Usticano; Lilli Mario Valenza; Luigi Montalbano; Giuseppina Pomara; Antonio Craxì
Journal:  J Med Virol       Date:  2002-07       Impact factor: 2.327

View more
  434 in total

1.  A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.

Authors:  Michael C Sneller; Zonghui Hu; Carol A Langford
Journal:  Arthritis Rheum       Date:  2012-03

Review 2.  Host genetic basis for hepatitis C virus clearance: a role for blood collection centers.

Authors:  Suganya Selvarajah; Leslie H Tobler; Graham Simmons; Michael P Busch
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

Review 3.  Treatment of HCV in Patients who Failed First-Generation PI Therapy: a Review of Current Literature.

Authors:  Paul Y Kwo; Maaz B Badshah
Journal:  Curr Gastroenterol Rep       Date:  2015-10

4.  Association between MTHFR A1298C polymorphism and hepatocellular carcinoma risk.

Authors:  Haiyan Zhang; Guang Li; Zhen Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

5.  Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses.

Authors:  Babita Agrawal; Rakesh Kumar
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

6.  Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.

Authors:  David Goldberg; Ivo C Ditah; Kia Saeian; Mona Lalehzari; Andrew Aronsohn; Emmanuel C Gorospe; Michael Charlton
Journal:  Gastroenterology       Date:  2017-01-11       Impact factor: 22.682

7.  Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis.

Authors:  Hiroyoshi Doi; Shiroh Tanoue; David E Kaplan
Journal:  Clin Immunol       Date:  2013-12-17       Impact factor: 3.969

8.  Interferon alpha induced intrahepatic pSTAT1 inversely correlate with serum HCV RNA levels in chronic HCV infection.

Authors:  Feyza Gunduz; Chaithanya Mallikarjun; Luis A Balart; Srikanta Dash
Journal:  Exp Mol Pathol       Date:  2013-11-08       Impact factor: 3.362

9.  HCV infection selectively impairs type I but not type III IFN signaling.

Authors:  Partha K Chandra; Lili Bao; Kyoungsub Song; Fatma M Aboulnasr; Darren P Baker; Nathan Shores; William C Wimley; Shuanghu Liu; Curt H Hagedorn; Serge Y Fuchs; Tong Wu; Luis A Balart; Srikanta Dash
Journal:  Am J Pathol       Date:  2013-11-09       Impact factor: 4.307

10.  Predictors of alcohol use among rural drug users after disclosure of hepatitis C virus status.

Authors:  Dustin B Stephens; Jennifer R Havens
Journal:  J Stud Alcohol Drugs       Date:  2013-05       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.